Registration
THE KPM GROUP DC LLC for GENSIGHT BIOLOGICS S.A.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| ALEXANDER ROOT New | — |
Pharmacy PHA
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| ALEXANDER ROOT New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | France | France | 100.0% | $31,500 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.